Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration (AMD) that can lead to visual impairment. Published studies estimate approximately 1 million people in the United States have GA in at least 1 eye. There is a lack of real-world evidence from the US payer perspective on the prevalence of AMD and GA among Medicare Advantage prescription drug (MAPD) plan enrollees. test
Pharmacy
01/23/2025
Annual Prevalence of Geographic Atrophy and Wet Age-Related Macular DeGeneration Among Medicare Advantage Enrollees in a US Health Plan
By: Vishal Saundankar, BPharm, MS, Mark Borns, PharmD, Kelly Broderick, PharmD, Birva Shah, OD, Stuart Cowburn, MS, Steven McFadden, PharmD, and Brandon Suehs, PharmD, PhD
